Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
RIVM monitoring local radiological measurements in Ukraine Reports from Ukraine indicate that there was fighting in the vicinity of the Zaporizhzhia nuclear power plant last night. RIVM has been actively monitoring the situation in Ukraine since the start of the disturbances.
General practitioners and occupational physicians not yet connected through Patiëntoverleg app General practitioners’ (GP) and occupational physicians’ (OP) use of the Patiëntoverleg app is still limited. They are often not yet aware of this app’s existence. These findings are from a study performed by RIVM.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
RIVM will calculate temporary background value for PFAS in soil In the coming weeks, RIVM will derive a temporary background value for PFAS in Dutch soil. This will be done based on measurement data from the provinces in the Netherlands.
RIVM reaction to farmers protest on 16 October 2019 On 16 October, farmers protested in the vicinity of RIVM in Bilthoven. The Director-General of RIVM, Hans Brug, was present at the protest site.
Openness about nitrogen There is concern about the current approach to nitrogen and the proposed measures; these concerns have been expressed in Dutch society as a whole and amongst farmers in particular.
Cold meat cuts probable source of 20 listeria cases RIVM has identified a cluster of 20 patients diagnosed with listeria over the past 2 years who are most likely to have been infected with an identical strain.
No health risks associated with foods and food supplements containing Krill and microalgae oils Consumption of foods and food supplements that contain oil from microalgae Schizochytrium sp. and Krill oil do not cause harm to our health.
No evidence of increased incidence of breast cancer with insulin glargine Insulin glargine is used in the treatment of diabetes.